Search

Introduction: The current COVID-19 pandemic had its first reported cases in December 2019 in Wuhan, Hubei province, China. COVID-19's pandemic status was recognized by the World Health Organization (WHO) on March 11, 2020. COVID-19 is a respiratory disease resulting from the infection caused by the new coronavirus. Most cases of infection are not serious, but some infected individuals require hospitalization and intensive care. Objective: To describe the clinical and epidemiological profile of patients admitted to the ICU-Covid-19 of Hospital Júlio Müller, Cuiabá-MT, from April to November 2020. Methodology: This is a retrospective, observational and descriptive study, carried out from the collection of information from medical records of patients admitted to the ICU COVID-19. Results: The sample of 99 patients corresponds to 51% male and 49% female, aged between 18 and 104 years, with a mean age of 49.5 years. Of these, 33% do not have any adjuvant disease; 67% have preexisting diseases, with 58% being cardiovascular diseases. As for ventilatory devices on admission of patients, 35% used invasive ventilatory support and 65% used spontaneous ventilation. Regarding the patients' outcome, 30% progressed to death, 69% progressed to ICU discharge and 1% was transferred from a hospital unit. [ABSTRACT FROM AUTHOR]

At the end of 2019, in Wuhan, China, a coronavirus pandemic started, later called SARS CoV 2 and identified as the cause of CO VID 19 disease. This virus is a public health concern due to its ease of transmission. This virus is a public health concern due to its ease of transmission. One way to reduce this spread is by reinforcing biosafety care, therefore, this research aimed to describe the biosafety measures that should be adopted by laboratories to contain the new coronavirus in the workplace and also present the effective ways of inactivating the virus in clinical samples. For this, a bibliographic review was carried out in the online database of the Virtual Health Library (VHL), using the descriptors "Coronavirus Infections" or "Coronavirus Infections" and "Biosafety". After applying the inclusion and exclusion criteria, thirteen papers were used to write this material. Subsequently, biosafety measures against SARS CoV 2 were described, sectioned by: work team, personal protective equipment, laboratory environment, sample handling, sample processing and analysis, accidents and virus inactivation in samples. It can be concluded that it is essential for the laboratory team to know the principles of biosafety, in order to try to reduce the transmission of the new coronavirus, in addition to continuous training for professionals and the adoption of strict protocols and guidelines. [ABSTRACT FROM AUTHOR]

COVID-19 is a disease caused by the new coronavirus (SARS-CoV-2), identified in Wuhan, China, in December 2019, and declared a pandemic by the World Health Organization in March 2020. Clinical manifestations occur mainly in respiratory system, however some studies have reported extra-pulmonary changes, such as oral and maxillofacial implications. This study aims to verify the possible oral and maxillofacial implications of COVID-19. Therefore, an integrative literature review was carried out. Systematic searches were carried out in SciELO, PubMed, Web of Science, Scopus and Google Scholar from June 6 to 8, 2020. Inclusion criteria were studies that evaluated oral and / or maxillofacial manifestations of COVID-19 and portrayed clinical cases of patients with the disease. Exclusion criteria were studies that were unavailable for reading in full, literature reviews and letters to the editor. Twelve studies were selected, in which the main manifestations were changes in taste and smell, dry mouth, ulcers in the oral mucosa and increase in cervical and submandibular lymph nodes, which may present together with other respiratory symptoms or in isolation. Because of this, the identification of some of these changes can contribute to the early diagnosis of the disease, however more studies are needed to improve the scientific evidence on the subject, to clarify whether part of these changes are manifestations of the disease or a consequence of the immune status of the patient. patient who favors the development of opportunistic infections and neglect of oral hygiene. [ABSTRACT FROM AUTHOR]